MINNEAPOLIS — UnitedHealth Group reported record earnings, attributing the surge to policyholders remaining untreated until condition resolution. CEO Andrew Witty praised the strategy, noting interventions are costly compared to natural outcomes. "We find mortality is significantly cheaper than chemotherapy," said VP of Actuarial Efficiency Sarah Jenkins.